Kevin Jones - MedMira Head Marketing

MIR Stock

CAD 0.08 0.01 6.67%

Insider

Kevin Jones is Head Marketing of MedMira

Age	55
Address	155 Chain Lake Drive, Halifax, NS, Canada, B3S 1B3
Phone	902 450 1588
Web	https://www.medmira.com

MedMira Management Efficiency

The company has return on total asset (ROA) of (0.2645) % which means that it has lost $0.2645 on every $100 spent on assets. This is way below average. MedMira's management efficiency ratios could be used to measure how well MedMira manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.69 in 2024. Return On Capital Employed is likely to drop to 0.13 in 2024. At this time, MedMira's Non Current Assets Total are fairly stable compared to the past year. Intangibles To Total Assets is likely to climb to 0.000001 in 2024, whereas Total Assets are likely to drop slightly above 1.7 M in 2024.

Compare MedMira to Peers

Predict price of MedMira

MedMira has accumulated 9.27 M in total debt. MedMira has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist MedMira until it has trouble settling it off, either with new capital or with free cash flow. So, MedMira's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MedMira sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MedMira to invest in growth at high rates of return. When we think about MedMira's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 11 records			INSIDER Age
	Kent Stout	Altagas Cum Red	N/A
	Phillip Burns	European Residential Real	55
	Jenny Chou	European Residential Real	N/A
	James Shelford	Altagas Cum Red	39
	George Wentworth	DelphX Capital Markets	N/A
	Joy Thakur	Altagas Cum Red	N/A
	MAAA FSA	DelphX Capital Markets	71
	Corine Bushfield	Altagas Cum Red	48
	Randall Crawford	Altagas Cum Red	60
	Esq BComm	Altagas Cum Red	N/A
	Jon Morrison	Altagas Cum Red	N/A

MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America and the Caribbean, Europe, the Asia Pacific, and internationally. The company was founded in 1993 and is headquartered in Halifax, Canada. MEDMIRA INC operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange. MedMira (MIR) is traded on TSX Venture Exchange in Canada and employs 5 people. MedMira is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Return On Asset

-0.26

MedMira Leadership Team

Elected by the shareholders, the MedMira's board of directors comprises two types of representatives: MedMira inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MedMira. The board's role is to monitor MedMira's management team and ensure that shareholders' interests are well served. MedMira's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MedMira's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Stewart McKelvey, Legal Counsel
	Markus Meile, Chief Officer
	Hermes Chan, Co-Founder, CEO and President Director, CEO of Medmira Laboratories Inc and President of Medmira Laboratories Inc
	Kevin Jones, Head Marketing
	Sam Ratnam, Director Affairs

MedMira Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MedMira a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Number Of Shares Shorted

979

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MedMira Stock Analysis

When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC